The reverse transcriptase‐polymerase chain reaction (RT‐PCR) was compared with
fluorescence in situ hybridization (FISH) and real‐time quantitative RT‐PCR (RQ‐PCR) for …

The monitoring of minimal residual disease (MRD) through low sensitivity real-time (RT)
polymerase chain reaction (PCR) analysis of BCR-ABL transcripts allows early detection of …

To analyze the value of real time RT-PCR for monitoring of bcr-abl expression in CML
patients after allogeneic or autologous stem cell transplantation (SCT), we generated pairs …

BACKGROUND. Chronic myeloid leukemia (CML) is a disease characterized by the
presence of a unique molecular marker, ie the fusion gene bcr-abl and its mRNA and protein …

The reverse transcriptase–polymerase chain reaction (RT-PCR) has become widely used
for monitoring minimal residual disease after allogeneic stem cell transplantation (SCT) for …

In chronic myelogenous leukemia (CML), amplification of a segment of bcr-abl messenger
RNA (mRNA) by polymerase chain reaction (PCR) can be used to detect minimal residual …

Real‐time reverse‐transcription polymerase chain reaction (RT‐PCR)(qPCR) of the BCR‐
ABL mRNA is a suitable technique to measure the amount of circulating leukemic cells in …

Quantitative reverse transcription-polymerase chain reaction (Q-RT-PCR) assessing the
amount of transcripts of the BCR/ABL gene, the molecular marker of chronic myeloid …

We studied 346 patients after bone marrow transplantation (BMT) for chronic myeloid
leukemia (CML) for the presence of the bcr-abl transcript detected by the polymerase chain …

BACKGROUND AND OBJECTIVES: The limited value of qualitative reverse transcription
polymerase chain-reaction (RT-PCR) for monitoring chronic myeloid leukemia (CML) …